Transthyretin-Associated Familial Amyloid Polyneuropathy - Current and Emerging Therapies

European Neurological Review - United Kingdom
doi 10.17925/enr.2012.07.01.14
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Transthyretin Glu18, a New Variant Associated With Familial Amyloid Polyneuropathy

Journal of the University of Malaya Medical Centre
Medicine
1998English

Psy87 - Economic Burden of Transthyretin Familial Amyloid Polyneuropathy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Transthyretin Familial Amyloid Polyneuropathy Impact on Health-Related Quality of Life

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Positive Real-World Effectiveness of Tafamidis for Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

Journal of Neuromuscular Diseases
Neurology
2015English

A Transthyretin Variant (Alanine 71) Associated With Familial Amyloidotic Polyneuropathy in a French Family.

Journal of Medical Genetics
Genetics
1993English

Noninvasive Cardiovascular Findings in Familial Amyloid Polyneuropathy.

Heart
Cardiovascular MedicineCardiology
1978English

Therapeutic Strategy for Familial Amyloid Polyneuropathy (FAP)

Clinical Neurology
Neurology
2009English

A Transthyretin Variant (Alanine 49) Associated With Familial Amyloidotic Polyneuropathy in a French Family.

Journal of Medical Genetics
Genetics
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy